New Drugs Puma Biotechnology Receives U.S. FDA Approval of Supplemental New Drug Application for Neratinib to Treat HER2-Positive Metastatic Breast Cancer 6 years ago
Pharma Industry News Genentech pays $30m upfront to access Bicycle Therapeutic’s discovery technology 6 years ago